Efficacy and safety of belimumab in lupus nephritis patients: a real-world observational study in China
BACKGROUND: This study aimed to describe disease activity, clinical outcome and overall patterns of lupus nephritis care in patients who received belimumab in a real-world clinical setting in China. MATERIALS AND METHODS: This observational cohort study included lupus nephritis patients who received...
Saved in:
Main Authors: | Meng Tan (Author), Jing Xu (Author), Ying Tan (Author), Zhen Qu (Author), Feng Yu (Author), Minghui Zhao (Author) |
---|---|
Format: | Book |
Published: |
Karger Publishers,
2023-02-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Belimumab for systemic lupus erythematosus - Focus on lupus nephritis
by: Marlene Plüß, et al.
Published: (2022) -
FDA approves belimumab for treatment of children with lupus nephritis
by: article Editorial
Published: (2022) -
Effectiveness and safety of belimumab in Chinese adult lupus nephritis patients: a 24-week retrospective single-center real-world study
by: Pei-pei Jiang, et al.
Published: (2024) -
Serum IFN-γ Predicts the Therapeutic Effect of Belimumab in Refractory Lupus Nephritis Patients
by: Liu S, et al.
Published: (2024) -
Belimumab in systemic lupus erythematosus
by: Ankita Srivastava
Published: (2016)